Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|February 16, 2005
Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIFKui Li, Eileen Foy, Josephine C Ferreon, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 3, 2021
Interleukin-18 and tumor necrosis factor-α are elevated in solid organ transplant recipients with possible cytomegalovirus end-organ diseaseAndrew H Karaba, Alexis Figueroa, William A Werbel, et al.
Microbiology Research|June 28, 2021
Molecular epidemiology of GB type C virus among individuals exposed to hepatitis C virus in CameroonJudith N Torimiro, Qing Mao, Nathan D Wolfe, et al.
The Journal of Infectious Diseases|March 11, 2015
CD4+ T-Cell-Dependent Reduction in Hepatitis C Virus-Specific Neutralizing Antibody Responses After Coinfection With Human Immunodeficiency VirusJustin R Bailey, Kimberly A Dowd, Anna E Snider, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 1, 2019
Correlates of hepatitis C viral clustering among people who inject drugs in BaltimoreJada Hackman, Oluwaseun Falade-Nwulia, Eshan U Patel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 5, 2005
Humoral immune response in acute hepatitis C virus infectionDale M Netski, Tim Mosbruger, Erik Depla, et al.
The Journal of Clinical Investigation|December 16, 2014
Naturally selected hepatitis C virus polymorphisms confer broad neutralizing antibody resistanceJustin R Bailey, Lisa N Wasilewski, Anna E Snider, et al.
Hepatology (Baltimore, Md.)|February 15, 2012
Laser captured hepatocytes show association of butyrylcholinesterase gene loss and fibrosis progression in hepatitis C-infected drug usersSupriya Munshaw, Hyon S Hwang, Michael Torbenson, et al.
Pageof 12